A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery

Completed

Conditions studied: Anterior Chamber Inflammation, Ocular Pain, Corneal Edema, Corneal Defect, Penetrating KeratoPlasty, Nuclear Cataract, Cortical Cataract, Cataract Senile

In brief

A Retrospective Review of Pain and Inflammation Resolution Outcomes in Patients Who Received DEXTENZA Intracanalicular Dexamethasone (0.4 mg) Insert Prior to or Following Corneal transplant or Cataract surgery

Key facts

Study ID

NCT04975971

Run by

Nicole Fram M.D.

People needed

25

Starts

2021-03-09

Expected to finish

2021-05-19

Last updated by the study team

2021-07-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 years and older
• Patients who received DEXTENZA insertion perioperatively.

You may not qualify if…

• Any patient who did not receive DEXTENZA insertion

Where it is running

• Advanced Vision Care — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.